# Evaluation of 3 Different Doses of IV Busulfan

> **NCT01985061** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Institut Paoli-Calmettes** · enrollment: 177 (estimated)

## Conditions studied

- Myelodysplastic Syndrome
- Acute Myeloid Leukemia

## Interventions

- **DRUG:** BX2
- **DRUG:** BX3
- **DRUG:** BX4-Suspended

## Key facts

- **NCT ID:** NCT01985061
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-12
- **Primary completion:** 2026-07-07
- **Final completion:** 2026-07-07
- **Target enrollment:** 177 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01985061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01985061, "Evaluation of 3 Different Doses of IV Busulfan". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01985061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*